A congressional proposal to sever ties between United States and Chinese biopharmaceutical companies is far from a done deal, but its bipartisan support is a concrete reminder to consider options for supply chain...more
The U.S. government’s national security and economic priorities around encouraging and adopting innovation is on full display in the soon-to-be-finalized Fiscal Year 2023 National Defense Authorization Act (NDAA). In this...more
12/16/2022
/ Artificial Intelligence ,
Biden Administration ,
Cloud Service Providers (CSPs) ,
Cybersecurity ,
Data Management ,
Department of Defense (DOD) ,
Department of Energy (DOE) ,
Innovation ,
Life Sciences ,
National Security ,
NDAA ,
Popular ,
Regulatory Agenda ,
Technology Sector ,
Trade Relations